RN

Reshma Nandkumar Kulkarni

Active Director Director DIN 10930221
DIN 10930221 First appointment Jan 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Reshma Nandkumar Kulkarni

Data last updated:

Reshma Nandkumar Kulkarni is a Director at Curaspark Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 10930221
Primary Designation Director
Industry Pharma
First Appointment 29 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Jan 20252025Active

Board colleagues of Reshma Nandkumar Kulkarni

Directorship timeline

Open interactive timeline →
Curaspark Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Reshma Nandkumar Kulkarni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Reshma Nandkumar Kulkarni

Reshma Nandkumar Kulkarni currently holds 1 directorship: Curaspark Pharmaceuticals Private Limited (Director, since 29 Jan 2025).

Reshma Nandkumar Kulkarni was first appointed on 29 Jan 2025 as Director at Curaspark Pharmaceuticals Private Limited.

The current boards of Reshma Nandkumar Kulkarni's companies include Nandkumar Kishanrao Kulkarni (Curaspark Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available